Global Adipose-derived Stem Cell Market is predicted to grow at a 10.0% CAGR during the forecast period for 2025-2034.
ADSCs are called multipotent cells, and they play several intercellular roles in the renewal and regeneration of other tissues and cell types in the body. This is because these cells produce and secrete various cytokines, chemokines, and growth factors that function in a paracrine manner in in-vivo tissue regeneration. It is usual to extract them using liposuction or direct excision technique from abdominal adipose (fat) tissues. For instance, Adipose-derived stem cells (ADSCs) have the potential to differentiate into musculoskeletal system cell types like tendons, ligaments, and articular cartilage.
The Isolation is a success rate of 100%, and the yield from adipose tissue is 40, significantly more significant than that from bone marrow. In addition, the number of cells does not seem to decrease with age, making this type of cell appealing for extracting MSCs and progenitor cells. Although adipose-derived stem cell therapy is often regarded as a safe operation with few potential adverse effects, difficulties can arise with any kind of medical treatment. Rising regulatory support for clinical trials of ADSCs pharmaceuticals and rising investment in the research and development of regenerative therapies are two significant factors propelling the growth of the adipose-derived stem cell market. To hasten the search for and Isolation of novel therapeutics, also there has been a rise in strategic partnerships formed between academic research institutions and pharmaceutical companies. For instance, In 2019, InGeneron Increases Its Series D Financing Amount to 43 Million Dollars in Order to Bring Regenerative Cell Therapy to Clinics.
Infection is a potential complication of adipose-derived stem cell therapy due to the possibility that disease-causing bacteria, viruses, or other pathogens will be introduced during the processing phase. Also, there are some limitations to preserving and delivering the cells, which will restrict the market growth.
The global Adipose-derived Stem Cell Market is segmented in five main segments. First is Cell type which includes Autologous and Allogeneic stem cells. Second segment is product type which comprises cell line, culture media, media, sera and reagents. The third segment is disease conditions. This segment has cancer, obesity, wounds and injuries, cardiovascular diseases, Musculoskeletal diseases and others. The fourth segment has Therapeutic and research as sub-segments which will be going to lead among all the segmentation for the forecasting period. The last segment is based on end-user industries, which are cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Other end-user industries.
Regionally North America will represent an entire market of ADSCs. Research and development funding has been increasing continuously over the last decade, which will result in early and more advancements in this therapeutic area.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 10.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Cell Type, End User Industry, Disease Indication, Product Type, Application. |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Allocure, Inc.,Celgene Corporation, Pluristem Therapeutics, Inc. (Pluri, Inc), Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast Ltd., Cytori Therapeutics, Antria, Inc., ThermoFisher Scientific, American CrysoStem, Merck KGaA, Other Prominent players.and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Adipose-derived Stem Cell Market Snapshot
Chapter 4. Global Adipose-derived Stem Cell Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Cell Type Estimates & Trend Analysis
5.1. By Cell Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Cell Type:
5.2.1. Autologous stem cells
5.2.2. Allogeneic stem cells
Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
6.2.1. Cell line
6.2.2. Culture Media
6.2.3. Media
6.2.4. Sera
6.2.5. Reagents
Chapter 7. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis
7.1. By Disease Indication & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
7.2.1. Cancer
7.2.2. Obesity
7.2.3. Wounds and Injuries
7.2.4. Cardiovascular diseases
7.2.5. Musculoskeletal diseases
7.2.6. Others
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Application & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
8.2.1. Therapeutic
8.2.2. Research
8.2.3. Others
Chapter 9. Market Segmentation 5: By End-user Estimates & Trend Analysis
9.1. By End-user & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
9.2.1. Cell banks & Tissue banks
9.2.2. Research laboratories and Academic institutes
9.2.3. Hospitals and Trauma centers
9.2.4. Others
Chapter 10. Adipose-derived Stem Cell Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Cell Type, 2021-2034
10.1.2. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
10.1.3. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.1.4. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.1.5. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.1.6. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2021-2034
10.2.2. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2021-2034
10.2.3. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.2.4. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.2.5. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.2.6. Europe Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2021-2034
10.3.2. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2021-2034
10.3.3. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.3.4. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.3.5. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.3.6. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million) 2021-2034
10.4.2. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
10.4.3. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.4.4. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.4.5. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.4.6. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.5.4. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.5.5. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.5.6. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Allocure, Inc.
11.2.2. Celgene Corporation
11.2.3. Pluristem Therapeutics, Inc.
11.2.4. Intrexon, Inc.
11.2.5. Celleris SA
11.2.6. Tissue Genesis, Inc.
11.2.7. Mesoblast Ltd.
11.2.8. Cytori Therapeutics
11.2.9. Antria, Inc.
11.2.10. ThermoFisher Scientific,
11.2.11. American CrysoStem
11.2.12. Merck KGaA
11.2.13. Others
11.2.14. Other Prominent Players
Global Adipose-derived Stem Cell Market, by Cell Type,
• Autologous stem cells
• Allogeneic stem cells
Global Adipose-derived Stem Cell Market, by Product Type,
• Cell line
• Culture Media
• Media
• Sera
• Reagents
Global Adipose-derived Stem Cell Market, by Disease Indication,
• Cancer
• Obesity
• Wounds and Injuries
• Cardiovascular diseases
• Musculoskeletal diseases
• Others
Global Adipose-derived Stem Cell Market, by Application,
• Therapeutic
• Research
• Others
Global Adipose-derived Stem Cell Market, by End-User Industry,
• Cell banks & Tissue banks
• Research laboratories and Academic institutes
• Hospitals and Trauma centers
• Others
Global Adipose-derived Stem Cell Market, by Region,
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
